Cyp2d6 metabolizer phenotype predicts aripiprazole pharmacokinetics in children and adolescents

JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY(2023)

引用 0|浏览10
暂无评分
摘要
The objectives of this presentation are to evaluate the impact of the cytochrome P450 enzyme, 2D6 (CYP2D6) phenotype on aripiprazole and dehydroaripiprazole pharmacokinetics in youth.
更多
查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要